JavaScript is disabled.
Some features may not work properly. For the best experience, please enable JavaScript in your browser.
Ledgeburg
Sign In
Loading...
News
Latest
Latest News
Stocks
Discover
Search Stocks
ETFs
Discover
Search ETFs
Funds
Discover
Search Funds
NAMSW - Newamsterdam Pharma Co. NV
USD | NASDAQ | Healthcare
Summary
Summary NAMSW Stock
Financials
Financials NAMSW Stock
Loading...
Loading...
Income Statement
Income Statement NAMSW Stock
Balance Sheet
Balance Sheet NAMSW Stock
Cash Flow Statement
Cash Flow Statement NAMSW Stock
Loading...
Loading...
Home
Stocks
Newamsterdam Pharma Co. NV (NAMSW)
Financials
Financials of NAMSW
Loading...
Loading...
NAMSW Financials - Newamsterdam Pharma Co. Income & Cash Flow | Ledgeburg
Loading...
Loading...
Revenue
$22.503M
Operating Income
$-225.683M
Net Income
$-203.819M
Share Count (Basic)
118.424231M
Operating Cash Flow
$-147.783M
Free Cash Flow
$-148.029M
Cash And Short-Term Equivalents
$636.241M
Total Debt
N/A
Annual
Quarterly
Revenue $USD
0
20M
40M
60M
80M
100M
FY2022
FY2023
FY2024
FY2025
Revenue $USD
0
5M
10M
15M
20M
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
Annual
Quarterly
Net Income $USD
-250M
-200M
-150M
-100M
-50M
Annual
Quarterly
Margins
Gross
Operating
Net
-1000%
-500%
0%
FY2021
FY2022
FY2023
FY2024
FY2025
Net Income $USD
-60M
-40M
-20M
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
FY2021
FY2022
FY2023
FY2024
FY2025
Margins
Gross
Operating
Net
-200000%
-150000%
-100000%
-50000%
0%
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26